GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Onconic Therapeutics 476060.KQ · KRW

N/A · KOSDAQ · 🇰🇷 South Korea

Compare

11,610

-0.60%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

5 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 2Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Average target 21,420

Low
21,210
Average
21,420
Median
21,420
High
22,050

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027
Revenue₩89.39bn₩110.09bn
Revenue, highest₩92.92bn₩114.45bn
Revenue, lowest₩86.73bn₩106.82bn
Earnings per share2702.764903.55
Earnings per share, highest2809.805097.75
Earnings per share, lowest2622.484757.90
Analysts22

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

5 / 10

Revenue growth 0.0% a year over 10 years. Return on equity 21.9%.

Model fair value

15,948.03

From earnings 15,948.03, from revenue 15,785.02.

Piotroski score

6 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.